Microorganism |
|
|
|
Antimicrobial |
![sort sort](../Images/sort_asc.gif) |
|
Reference |
Escherichia coli (Europe) |
- |
0.06 |
? - ? |
Meropenem (Merrem)![](/Images/relation.png) |
284 |
Escherichia coli (Europe) |
- |
0.13 |
? - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)![](/Images/relation.png) |
284 |
Escherichia coli (Europe) |
- |
0.25 |
? - ? |
Cefotaxime (Cephotaxime, Claforan)![](/Images/relation.png) |
284 |
Escherichia coli (Europe) |
- |
0.5 |
? - ? |
Imipenem![](/Images/relation.png) |
284 |
Escherichia coli (Europe) |
- |
1 |
? - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef)![](/Images/relation.png) |
284 |
Escherichia coli (Europe) |
- |
2 |
? - ? |
Zosyn![](/Images/relation.png) |
284 |
Escherichia coli (Europe) |
>- |
>128 |
? - ? |
Piperacillin (Pipracil)![](/Images/relation.png) |
284 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
≤0.004 |
≤0.004 |
≤0.004 - <=0.004 |
Sitafloxacin![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
≤0.004 |
≤0.004 |
≤0.004 - <=0.004 |
Sitafloxacin![](/Images/relation.png) |
130 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 - 0.008 |
DK-507k![](/Images/relation.png) |
130 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 - 0.008 |
Gemifloxacin![](/Images/relation.png) |
268 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 - 0.015 |
Garenoxacin (T-3811, BMS-284756)![](/Images/relation.png) |
268 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 - 8 |
DK-507k![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 - 0.008 |
Gatifloxacin (Tequin)![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 - 0.008 |
Gatifloxacin (Tequin)![](/Images/relation.png) |
130 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 - 0.015 |
Garenoxacin (T-3811, BMS-284756)![](/Images/relation.png) |
130 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 - 0.015 |
Garenoxacin (T-3811, BMS-284756)![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 - 0.08 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)![](/Images/relation.png) |
268 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 - 0.015 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)![](/Images/relation.png) |
130 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 - 0.015 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 - 0.015 |
DC-159a![](/Images/relation.png) |
268 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.015 |
0.008 - 0.015 |
Levofloxacin (Levaquin, Quixin)![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.015 |
0.008 - 0.03 |
Moxifloxacin (BAY 12-8039, Avelox)![](/Images/relation.png) |
268 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.03 |
0.008 - 0.03 |
Moxifloxacin (BAY 12-8039, Avelox)![](/Images/relation.png) |
130 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.015 |
0.03 |
0.008 - 0.03 |
Moxifloxacin (BAY 12-8039, Avelox)![](/Images/relation.png) |
443 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.12 |
0.5 |
≤0.012 - 0.5 |
Chloramphenicol (Chloromycetin)![](/Images/relation.png) |
267 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
0.12 |
1 |
≤0.015 - 1 |
Cefixime (Suprax)![](/Images/relation.png) |
267 |
Haemophilus influenzae (non-ESBL + ampicillin-resistant) |
1 |
2 |
0.25 - 4 |
Cefdinir (Omnicef, Cefdiel)![](/Images/relation.png) |
267 |